| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 268 | 166 | 28 |
| Full Text Views | 1 | 1 | 0 |
| PDF Downloads | 2 | 2 | 0 |
Fluorescent Antibody Test in Amebiasis
Clinical Applications
Pierre Ambroise-Thomas
Pierre Ambroise-Thomas
Laboratory of Parasitology and Exotic Pathology, School of Medicine, Laboratory of Parasitology, School of Medicine, Grenoble, France
Search for other papers by Pierre Ambroise-Thomas in
Current site
Google Scholar
PubMed
Search for other papers by Pierre Ambroise-Thomas in
Current site
Google Scholar
PubMed
Thai Kien Truong
Thai Kien Truong
Laboratory of Parasitology and Exotic Pathology, School of Medicine, Laboratory of Parasitology, School of Medicine, Grenoble, France
Search for other papers by Thai Kien Truong in
Current site
Google Scholar
PubMed
Search for other papers by Thai Kien Truong in
Current site
Google Scholar
PubMed
For the serologic diagnosis of amebiasis in man, the indirect immunofluorescence test (IFT) was used in a study of 3,607 sera, 1,217 of which were used to check specificity. In cases of hepatic amebiasis the IFT was constantly and intensely positive, and therefore has a very high diagnostic value. It can also be used to assess the effect of therapy, but only several months after treatment has begun. However, the IFT cannot be relied on for the diagnosis of amebic dysentery, since in such cases its only advantage is the elimination of the possibility of hepatic complications. It cannot be used to distinguish between chronic amebiasis and post-amebic colitis, or to detect asymptomatic cyst passers. Like other serologic methods, the IFT therefore has precisely defined limitations in the diagnosis of amebiasis. Its principal advantages are that it is easy to carry out and has a high level of reproducibility.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 268 | 166 | 28 |
| Full Text Views | 1 | 1 | 0 |
| PDF Downloads | 2 | 2 | 0 |